PHOTODYNAMIC THERAPY OF CONDYLOMATA ACUMINATE

Reliably established a causal role of human papillomavirus in the formation of condylomata acuminate. In 10% of people with the human papilloma virus develops condylomata acuminate, which can be transformed into malignant tumors. The most common treatment of condylomata acuminate is a conservative treatment, namely, the local chemical or physical destruction of the lesions and immunotherapy. With the ineffectiveness of conservative treatment resort to surgical excision. At the same time the traditional methods of treatment condylomata acuminate associated with high rates of recurrence. Moreover, these treatments are often associated with significant risk of bleeding, ulceration and scarring. The emergence of new methods of diagnosis and treatment of condylomata acuminate – fluorescence diagnosis and photodynamic therapy has opened up new opportunities to improve the treatment of this pathology. Topical administration of photosensitizers during photodynamic therapy is more convenient and less phototoxic and broaden the range of clinical applications of this technology in the medical dermatology. An increasing amount of evidence that photodynamic therapy with topical application of the photosensitizer is highly effective in the treatment of a variety of benign skin diseases, including condylomata acuminataca, for which traditional methods are ineffective treatment. However, many parameters of photodynamic therapy of this disease has not yet been optimized. It is necessary to conduct large-scale clinical studies on the effectiveness of photodynamic therapy of condylomata acuminatain order to standardize the treatment parameters.

1. Fleischer A. B. Jr., Parrish C. A., Glenn R., Feldman S. R. Condylomata acuminata (genital warts): patient demographics and treating physicians. Sex Transm Dis. 2001; 28: 43–47.

2. Brentjens M.H., Yeung-Yue K. A., Lee P. C., Tyring S. K. Human papillomavirus: a review. Dermatol Clin. 2002; 20: 315–331.

3. Aubin F., Prétet J. L., Jacquard A. C., Saunier M., Carcopino X., Jaroud F., Pradat P., Soubeyrand B., Leocmach Y., Mougin C., Riethmuller D., EDiTH Study Group. Human papillomavirus genotype distribution in external acuminata condylomata: a large French national study (EDiTH IV). Clin Infect Dis. 2008; 47: 610–615.

4. Trottier H., Burchell A.N. Epidemiology of mucosal human papilloma virus infection and associated diseases. Public Health Genomics. 2009; 12: 291–307.

5. Forcier M., Musacchio N. An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention. Dermatol Ther. 2010; 23 (5): 458–476.

6. Mehrabani D., Behzadi M. A., Azizi S., Payombarnia H., Vahdani A., Namayandeh M., Ziyaeyan M. Cervical Infection with Herpes simplex Virus, Chlamydia trachomatis, and Neisseria gonorrhoeae among Symptomatic Women, Dubai, UAE: A Molecular Approach. Interdiscip Perspect Infect Dis. 2014; 2014: 347602.

7. Muñoz N., Bosch F. X., de Sanjosé S., Herrero R., Castellsagué X., Shah K. V., Snijders P.J., Meijer C.J., International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348: 518–527.

8. Koutsky L. Epidemiology of genital human papilloma virus infection. Am J Med. 1997; 102: 3–8.

9. Mao C., Hughes J. P., Kiviat N., Kuypers J., Lee S. K., Adam D. E., Koutsky L. A. Clinical findings among young women with genital human papillomavirus infection. Am J Obstet Gynecol. 2003; 188: 677–684.

10. Stanley M. Immune responses to human papilloma virus. Vaccine. 2006; 24: S16–S22.

11. Reid J. L., Wright T. C., Jr, Stoler M.H., Cuzick J., Castle P. E., Dockter J., Getman D., Giachetti C. Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study. Am J Clin Pathol. 2015; 144 (3): 473–483.

12. Jablonska S. Traditional therapies for the treatment of condylomata acuminata (genital warts). Austr J Dermatol. 1998; 39: S2–S4.

13. Rhea W.G. Jr., Bourgeois B. M., Sewell D. R. Condyloma acuminata: a fatal disease? Am Surg. 1998; 64 (11): 1082–1087.

14. Lacey C.J., Woodhall S. C., Wikstrom A., Ross J. 2012 European guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol. 2013; 27: e263–270.

15. Schneede P., Münch P., Wagner S., Meyer T., Stockfleth E., Hofstetter A. Fluorescence urethroscopy following instillation of 5 aminolevulinic acid: a new procedure for detecting clinicaland subclinical HPV lesions of the urethra. J Eur Acad Dermatol Venereol. 2001; 15 (2): 121–125.

16. Rai R. Phototherapy: An update. Indian J Dermatol Venereol Leprol. 2009; 75: 634–637.

17. Fehr M. K., Chapman C. F., Krasieva T., Tromberg B.J., McCullough J. L., Berns M.W., Tadir Y. Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5 aminolevulinic acid. Am J Obstet Gynecol. 1996; 174: 951–957.

18. Ross E. V., Romero R., Kollias N., Crum C., Anderson R. R. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5 aminolaevulinic acid: Implications for photodynamic treatment. Br J Dermatol. 1997; 137: 736–742.

19. Ichimura H., Yamaguchi S., Kojima A., Tanaka T., Niiya K., Takemori M., Hasegawa K., Nishimura R. Eradication and reinfection of human papillomavirus after photodynamic therapy for cervical intraepithelial neoplasia. Int J Clin Oncol. 2003; 8:322–325. 2

20. Chen K., Chang B. Z., Ju M., Zhang X.H., Gu H. Comparative study of photodynamic therapy vs CO2 laser vaporization in treatment of condylomata acuminata: A randomized clinical trial. Br J Dermatol. 2007; 156: 516–520.

21. Istomin Y. P., Lapzevich T. P., Chalau V.N., Shliakhtsin S. V., Trukhachova T. V. Photodynamic therapy of cervical intraepithelial neoplasia grades II and III with Photolon. Photodiagnosis Photodyn Ther. 2010; 7: 144–151.

22. Wang J., Xu J., Chen J., He Q., Xiang L., Huang X., Ding G., Xu S. Successful photodynamic therapy with topical 5 aminolevulinic acid for five cases of cervical intraepithelial neoplasia. Arch Gynecol Obstet. 2010; 282: 307–312.

23. Nucci V., Torchia D., Cappugi P. Treatment of anogenital condylomata acuminata with topical photodynamic therapy: Report of 14 cases and review. Int J Infect Dis. 2010; 14 (Suppl. 3): e280–e282.

24. Molochkov V. A., Molochkova Yu. V. Indinol Forto i Egallokhit v terapii ostrokonechnykh i gigantskikh kondilom. Al'manakh klinicheskoy meditsiny. 2014; 34: 100–105.

25. Mchepange U.O., Huang C. Y., Sun Y., Tu Y. T., Tao J. Two-step irradiance schedule versus single-dose tramadol sustained-release tablets for pain control during topical 5 aminolevulinic acid-photodynamic therapy of condyloma acuminatum in Chinese patients: a randomized comparative study. Lasers Surg Med. 2014; 46 (5): 389–395.

26. Zhang Z., Lu X.N., Liang J., Tang H., Yang Y. S., Zhu X.H., Du J., Shen Y. Y., Xu J.H. Evaluation of photodynamic therapy using topical aminolevulinic acid hydrochloride in the treatment ofcondylomata acuminate. Int J Clin Exp Med. 2015; 8 (4): 6517–6521.

27. Liang J., Lu X.N., Tang H., Zhang Z., Fan J., Xu J.H. Evaluation of photodynamic therapy using topical aminolevulinic acid hydrochloride in the treatment of condylomata acuminata: A comparative, randomized clinical trial. Photodermatol Photoimmunol Photomed. 2009; 25: 293–297.

28. Wang X. L., Wang H.W., Wang H. S., Xu S. Z., Liao K.H., Hillemanns P. Topical 5 aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata. Br J Dermatol. 2004; 151: 880–885.

29. Szeimies R. M., Schleyer V., Moll I., Stocker M., Landthaler M., Karrer S. Adjuvant photodynamic therapy does not prevent recurrence of condylomata acuminata after carbon dioxide laser ablation-A phase III, prospective, randomized, bicentric, double-blind study. Dermatol Surg. 2009; 35: 757–764.

30. Huang J., Zeng Q., Zuo C., Yang S., Xiang Y., Lu J., Kang J., Tan L., Yu X., Xi C., Huang J., Kang L., Fan F., Chen J. The combination of CO2 laser vaporation and photodynamic therapy in treatment of condylomata acuminata. Photodiagnosis Photodyn Ther. 2014; 11 (2): 130–133.

31. Shan X., Wang N., Li Z., Hou J., Zheng R., Tian H., Zhang F. An open uncontrolled trial of topical 5 aminolevulinic acid photodynamic therapy for the treatment of urethralcondylomata acuminata in male patients. Indian J Dermatol Venereol Leprol. 2016; 82 (1): 65–67.